Robert W. Baird analyst Matthew Gillmor reiterated a Hold rating on LHC Group (NASDAQ: LHCG) on July 3 and set a price target of $83. The company’s shares closed on Tuesday at $87.79, close to its 52-week high of $87.91.
According to TipRanks.com, Gillmor is a 5-star analyst with an average return of 17.9% and a 67.7% success rate. Gillmor covers the Services sector, focusing on stocks such as Encompass Health Corporation, Envision Healthcare, and Hms Holdings Corp.
LHC Group has an analyst consensus of Strong Buy, with a price target consensus of $83.
See today’s analyst top recommended stocks >>
LHC Group’s market cap is currently $1.57B and has a P/E ratio of 34.56. The company has a Price to Book ratio of 3.48.
Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.
